Amgen Inc (FRA:AMG)
€ 304.75 5.05 (1.69%) Market Cap: 161.98 Bil Enterprise Value: 209.58 Bil PE Ratio: 41.65 PB Ratio: 23.23 GF Score: 91/100

Amgen Inc at Cowen Health Care Conference (Virtual) Transcript

Mar 08, 2022 / 04:10PM GMT
Release Date Price: €213.75 (-1.95%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Okay. Well, good morning, everybody, and thank you for joining us once again for the 42nd Annual Cowen Health Care Conference. I'm Yaron Werber, one of the biotech analysts here at Cowen. And it's a great pleasure today to moderate the fireside chat with Amgen. With us today, we have Peter Griffith, who is our EVP and Chief Financial Officer; Murdo Gordon, who is an EVP Global Commercial Ops, Head of Commercial Operations; Arvind Sood, VP of IR; and Omari Wise from Investor Relations as well.

If you have any questions, by all means, feel free to e-mail me directly, and I'll be happy to read them on your behalf or use the Wall Street Webcasting portal and I can read those as well. So gentlemen, thanks so much for joining us. We appreciate it.

Murdo Gordon
Amgen Inc. - Executive VP of Global Commercial Operations

Thanks, Yaron.

Peter H. Griffith
Amgen Inc. - Executive VP & CFO

Thank you, Yaron.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot